Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
72
NWHUF Quote, Financials, Valuation and Earnings
Last price:
$4.32
Seasonality move
:
-1.15%
Day range:
$4.32 - $4.35
52-week range:
$3.14 - $4.36
Dividend yield:
6.43%
P/E ratio:
30.08x
P/S ratio:
3.48x
P/B ratio:
0.93x
Volume:
501
Avg. volume:
4.5K
1-year change:
23.43%
Market cap:
$1.1B
Revenue:
$348.6M
EPS (TTM):
$0.14
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Northwest Healthcare Properties Real Estate Investment Trust has -- downside to fair value with a price target of -- per share.
NWHUF vs. S&P 500
-
Over the past 5 trading days, Northwest Healthcare Properties Real Estate Investment Trust has overperformed the S&P 500 by 2.77% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Northwest Healthcare Properties Real Estate Investment Trust does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Northwest Healthcare Properties Real Estate Investment Trust revenues have been falling on a year-over-year basis for 7 quarters in a row. In the most recent quarter Northwest Healthcare Properties Real Estate Investment Trust reported revenues of $78.6M.
Earnings Growth
-
Northwest Healthcare Properties Real Estate Investment Trust has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Northwest Healthcare Properties Real Estate Investment Trust reported earnings per share of $0.05.
Enterprise value:
3.8B
EV / Invested capital:
--
Price / LTM sales:
3.48x
EV / EBIT:
22.28x
EV / Revenue:
12.44x
PEG ratio (5yr expected):
-0.06x
EV / Free cash flow:
39.88x
Price / Operating cash flow:
11.16x
Enterprise value / EBITDA:
21.97x
Gross Profit (TTM):
$230.4M
Return On Assets:
0.86%
Net Income Margin (TTM):
12.11%
Return On Equity:
1.99%
Return On Invested Capital:
0.93%
Operating Margin:
56.12%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $381.6M | $367M | $309.4M | $81.5M | $78.6M | |
| Gross Profit | $290.4M | $280.6M | $230.4M | $62.8M | $60M | |
| Operating Income | $263.4M | $168M | $172.8M | $5.6M | $44.1M | |
| EBITDA | $264.4M | $170.6M | $175.2M | $6.1M | $44.6M | |
| Diluted EPS | -$0.95 | -$1.33 | $0.14 | -$0.41 | $0.05 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $128.7M | $68.4M | $80.8M | $74.9M | $76.8M | |
| Total Assets | $5.3B | $6B | $5.8B | $4.7B | $4.3B | |
| Current Liabilities | $818M | $1.3B | $359.3M | $266.4M | $461M | |
| Total Liabilities | $2.7B | $3.3B | $3.4B | $2.7B | $2.4B | |
| Total Equity | $2.5B | $2.7B | $2.4B | $2B | $1.9B | |
| Total Debt | $2.3B | $2.5B | $2.9B | $2.3B | $2.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $118M | $75M | $97.8M | $26.4M | $17.1M | |
| Cash From Investing | $22M | $451.2M | $154.8M | $136.7M | $6.8M | |
| Cash From Financing | -$140.3M | -$539.1M | -$248.1M | -$168.1M | -$28.6M | |
| Free Cash Flow | $117.9M | $74.3M | $96.5M | $26.4M | $17.1M | |
NWHUF
Sector
Market Cap
$1.1B
$938.7M
Price % of 52-Week High
99.14%
89.86%
Dividend Yield
6.43%
2.26%
Shareholder Yield
20.08%
3.36%
1-Year Price Total Return
23.43%
--
Beta (5-Year)
0.903
0.634
Dividend yield:
6.43%
Annualized payout:
$0.26
Payout ratio:
139.03%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$4.27
200-day SMA
Buy
Level
$3.71
Bollinger Bands (100)
Buy
Level
3.58 - 4.08
Chaikin Money Flow
Buy
Level
25.4K
20-day SMA
Buy
Level
$4.22
Relative Strength Index (RSI14)
Buy
Level
68.61
ADX Line
Buy
Level
16.99
Williams %R
Sell
Level
-18.8508
50-day SMA
Buy
Level
$3.99
MACD (12, 26)
Buy
Level
0.97
25-day Aroon Oscillator
Buy
Level
88
On Balance Volume
Neutral
Level
4.7K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.4647)
Sell
CA Score
(Annual)
Level (-1.389)
Buy
Beneish M-Score
(Annual)
Level (-3.7272)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (1.3938)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (4)
Sell
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Northwest Healthcare Properties Real Estate Investment Trust engages in the provision of access to a portfolio of international healthcare real estate infrastructure to investors. It operates through the following geographical segments: Europe, Canada, Brazil, and Australasia. The firm has interests in medical office buildings, clinics, and hospitals. The company was founded by Paul Dalla Lana in 2004 and is headquartered in Toronto, Canada.
Stock Forecast FAQ
In the current month, NWHUF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NWHUF average analyst price target in the past 3 months is --.
-
Where Will Northwest Healthcare Properties Real Estate Investment Trust Stock Be In 1 Year?
According to analysts, the consensus estimate is that Northwest Healthcare Properties Real Estate Investment Trust share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Northwest Healthcare Properties Real Estate Investment Trust?
Analysts are divided on their view about Northwest Healthcare Properties Real Estate Investment Trust share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Northwest Healthcare Properties Real Estate Investment Trust is a Sell and believe this share price will rise from its current level to --.
-
What Is Northwest Healthcare Properties Real Estate Investment Trust's Price Target?
The price target for Northwest Healthcare Properties Real Estate Investment Trust over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is NWHUF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Northwest Healthcare Properties Real Estate Investment Trust is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of NWHUF?
You can purchase shares of Northwest Healthcare Properties Real Estate Investment Trust via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Northwest Healthcare Properties Real Estate Investment Trust shares.
-
What Is The Northwest Healthcare Properties Real Estate Investment Trust Share Price Today?
Northwest Healthcare Properties Real Estate Investment Trust was last trading at $4.32 per share. This represents the most recent stock quote for Northwest Healthcare Properties Real Estate Investment Trust. Yesterday, Northwest Healthcare Properties Real Estate Investment Trust closed at $4.32 per share.
-
How To Buy Northwest Healthcare Properties Real Estate Investment Trust Stock Online?
In order to purchase Northwest Healthcare Properties Real Estate Investment Trust stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get NWHUF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NWHUF
Sector
P/E ratio
30.08x
18.50x
PEG ratio
-0.06x
0.05x
P/B ratio
0.93x
0.83x
Price / LTM sales
3.48x
3.22x
Growth Metrics
NWHUF
Sector
Revenue growth
-3.49%
2.37%
Earnings growth
111.4%
-1.55%
Revenue (5-year growth)
4.16%
3.41%
Earnings forecast
--
$0.13
Profitability
NWHUF
Sector
Profitability FY 2024
$263.4M
$147.2M
Return on invested capital
0.93%
1.8%
Return on assets
0.86%
1.68%
Return on equity
1.99%
3.34%
Earnings Date
Last Earnings Date
Nov
11
Next Earnings Date
Feb
24
Estimated Next Earnings Date
Feb
10
Balance Sheet
NWHUF
Sector
Total cash
$55.7M
$70.8M
Short term investments
--
$12.4M
Total assets
$4.2B
$3.2B
Long term debt
$2.1B
$338.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
77
RNG alert for Feb 21
RingCentral, Inc. [RNG] is up 34.37% over the past day.
Sell
9
FROG alert for Feb 21
JFrog Ltd. [FROG] is down 24.98% over the past day.
Buy
72
SNSE alert for Feb 21
Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
